EYA1 and BOR syndrome: WES performed as a clinical test with the presumed diagnosis of branchio-oto-renal syndrome (BOR) identified a heterozygous mutation in EYA1 (eyes absent transcriptional coactivator and phosphatase 1), a transcriptional factor that plays a role in development of the kidney, eye, ear, and branchial arches.